These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003. Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060 [TBL] [Abstract][Full Text] [Related]
3. Antipsychotic Medication Prescribing Practices Among Adult Patients Discharged From State Psychiatric Inpatient Hospitals. Ortiz G; Hollen V; Schacht L J Psychiatr Pract; 2016 Jul; 22(4):283-97. PubMed ID: 27427840 [TBL] [Abstract][Full Text] [Related]
4. Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization. Saldaña SN; Keeshin BR; Wehry AM; Blom TJ; Sorter MT; DelBello MP; Strawn JR Pharmacotherapy; 2014 Aug; 34(8):836-44. PubMed ID: 24990538 [TBL] [Abstract][Full Text] [Related]
5. Patterns of antipsychotics' prescription in Portuguese acute psychiatric wards: A cross-sectional study. Campos Mendes J; Azeredo-Lopes S; Cardoso G Psychiatry Res; 2016 Dec; 246():142-148. PubMed ID: 27693867 [TBL] [Abstract][Full Text] [Related]
6. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil. Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271 [TBL] [Abstract][Full Text] [Related]
7. The prevalence of antipsychotic polypharmacy in schizophrenic patients discharged from psychiatric units in Poland. Jaracz J; Tetera-Rudnicka E; Kujath D; Raczyńska A; Stoszek S; Czernaś W; Wierzbiński P; Moniakowski A; Jaracz K; Rybakowski J Pharmacol Rep; 2014 Aug; 66(4):613-7. PubMed ID: 24948062 [TBL] [Abstract][Full Text] [Related]
8. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study. Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250 [TBL] [Abstract][Full Text] [Related]
9. Determinants of antipsychotic polypharmacy in psychiatric inpatients: a prospective study. Biancosino B; Barbui C; Marmai L; Donà S; Grassi L Int Clin Psychopharmacol; 2005 Nov; 20(6):305-9. PubMed ID: 16192838 [TBL] [Abstract][Full Text] [Related]
10. Assessment of inpatient psychiatric readmission risk among patients discharged on an antipsychotic polypharmacy regimen: A retrospective cohort study. Boskailo E; Malkoc A; McCurry DB; Venter J; Drachman D; Ramos GM Acta Med Acad; 2017 Nov; 46(2):133-144. PubMed ID: 29338277 [TBL] [Abstract][Full Text] [Related]
11. Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital. Wu YH; Lai CY; Chang YS Psychogeriatrics; 2015 Mar; 15(1):7-13. PubMed ID: 25515355 [TBL] [Abstract][Full Text] [Related]
12. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study. Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645 [TBL] [Abstract][Full Text] [Related]
13. Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study. Ayani N; Morimoto T; Sakuma M; Kikuchi T; Watanabe K; Narumoto J J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):397-402. PubMed ID: 34108429 [TBL] [Abstract][Full Text] [Related]
14. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I Encephale; 2005; 31(2):235-46. PubMed ID: 15959450 [TBL] [Abstract][Full Text] [Related]
15. Antipsychotic polypharmacy at the University Psychiatric Hospital in Serbia. Divac N; Jasović-Gasić M; Samardzić R; Lacković M; Prostran M Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1250-1. PubMed ID: 17960865 [TBL] [Abstract][Full Text] [Related]
16. Prescription practices in the treatment of agitation in newly hospitalized Chinese schizophrenia patients: data from a non-interventional naturalistic study. Zhang SZ; Mu YG; Liu Q; Shi Y; Guo LH; Li LZ; Yang FD; Wang Y; Li T; Mei QY; He HB; Chen ZY; Su ZH; Liu TB; Xie SP; Tan QR; Zhang JB; Zhang CP; Sang H; Mi WF; Zhang HY BMC Psychiatry; 2019 Jul; 19(1):216. PubMed ID: 31291931 [TBL] [Abstract][Full Text] [Related]
17. Factors associated with antipsychotic polypharmacy and high-dose antipsychotics among individuals receiving compulsory treatment in the community. Gisev N; Bell JS; Chen TF J Clin Psychopharmacol; 2014 Jun; 34(3):307-12. PubMed ID: 24717256 [TBL] [Abstract][Full Text] [Related]
18. Antipsychotic polypharmacy in older Australians. Kalisch Ellett LM; Pratt NL; Kerr M; Roughead EE Int Psychogeriatr; 2018 Apr; 30(4):539-546. PubMed ID: 29122047 [TBL] [Abstract][Full Text] [Related]
20. Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison. Roh D; Chang JG; Kim CH; Cho HS; An SK; Jung YC Aust N Z J Psychiatry; 2014 Jan; 48(1):52-60. PubMed ID: 23671214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]